| 000 | 01468 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517095252.0 | ||
| 264 | 0 | _c20170306 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1769-7123 | ||
| 024 | 7 |
_a10.1016/j.resmic.2016.05.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXie, Yali | |
| 245 | 0 | 0 |
_aA rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. _h[electronic resource] |
| 260 |
_bResearch in microbiology _cOct 2016 |
||
| 300 |
_a625-629 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntibiosis |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xpharmacology |
| 650 | 0 | 4 |
_aAntifungal Agents _xmetabolism |
| 650 | 0 | 4 |
_aBiological Products _xmetabolism |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDNA-Directed RNA Polymerases _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aPseudomonas _xdrug effects |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aSecondary Metabolism |
| 700 | 1 | _aLiu, Zhengqiang | |
| 700 | 1 | _aZhang, Guoyong | |
| 700 | 1 | _aMo, Xiangtao | |
| 700 | 1 | _aDing, Xuezhi | |
| 700 | 1 | _aXia, Liqiu | |
| 700 | 1 | _aHu, Shengbiao | |
| 773 | 0 |
_tResearch in microbiology _gvol. 167 _gno. 8 _gp. 625-629 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.resmic.2016.05.001 _zAvailable from publisher's website |
| 999 |
_c26045187 _d26045187 |
||